Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.
Tanimoto
A
A
Department of Diagnostic Radiology, Keio University Hospital, Tokyo, Japan.
Yuasa
Y
Y
Stark
D D
DD
D003287:Contrast Media / Q000493:pharmacokinetics; D003911:Dextrans; D004338:Drug Combinations; D052203:Ferrosoferric Oxide; D019786:Gadolinium DTPA; D007501:Iron / Q000493:pharmacokinetics; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008536:Meglumine; D008961:Models, Structural; D009942:Organometallic Compounds; D010087:Oxides / Q000493:pharmacokinetics; D004369:Pentetic Acid / Q000031:analogs & derivatives
D003287:Contrast Media; D003911:Dextrans; D004338:Drug Combinations; D058185:Magnetite Nanoparticles; D009942:Organometallic Compounds; D010087:Oxides; D008536:Meglumine; D004369:Pentetic Acid; C025614:sephadex; D007501:Iron; C065507:ferumoxides; D019786:Gadolinium DTPA; D052203:Ferrosoferric Oxide